Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Zai Lab Ltd ADR (NQ: ZLAB ) 25.61 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Zai Lab Ltd ADR < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > Stitch Fix Reports Weak Earnings, Joins KB Home And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session September 25, 2024 Via Benzinga Zai Lab to Present Preclinical Data of ZL-1503, an IL-13/IL-31 Bispecific Antibody for the Treatment of Atopic Dermatitis, at EADV Congress 2024 September 17, 2024 From Zai Lab Limited Via Business Wire Zai Lab to Present Preliminary Data From Phase 1 Trial of ZL-1218, an Investigational Anti-CCR8 Antibody for the Treatment of Advanced Solid Tumors, at ESMO Congress 2024 August 27, 2024 From Zai Lab Limited Via Business Wire Zai Lab Announces Participation in September Investor Conferences August 22, 2024 From Zai Lab Limited Via Business Wire Zai Lab Announces Second Quarter 2024 Financial Results and Recent Corporate Updates August 06, 2024 From Zai Lab Limited Via Business Wire Why Is Zynex (ZYXI) Stock Down 24% Today? July 26, 2024 Zynex stock is falling on Friday as ZYXI investor react to earnings misses and poor guidance for Q3 and the full year of 2024. Via InvestorPlace Topics Earnings Exposures Financial Why Is DexCom (DXCM) Stock Down 38% Today? July 26, 2024 DexCom stock is up on Friday as DXCM investors react to the company's latest earnings report and its lackluster 2024 guidance. Via InvestorPlace Trade of the Day: Zai Lab (ZLAB) Stock Is a Possible Hidden Gem July 26, 2024 A compelling hidden-gem opportunity, Zai Lab’s groundbreaking cancer therapeutic and discounted valuation could drive up ZLAB stock. Via InvestorPlace Zai Lab and argenx Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China July 16, 2024 From Zai Lab Limited Via Business Wire Zai Lab-Supported Study Published in Cell Provides New Insights with Potential to Improve Treatment of HRD-Positive Ovarian Cancers, Including Through Combination PARP Inhibitor and CCR8 Therapy July 15, 2024 From Zai Lab Limited Via Business Wire Zai Lab to Announce Second Quarter 2024 Financial Results and Recent Corporate Updates on August 6, 2024 July 10, 2024 From Zai Lab Limited Via Business Wire Zai Lab Announces Dr. Harald Reinhart to Retire as Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases; Dr. Rafael Amado to be Appointed President, Head of Global R&D June 11, 2024 From Zai Lab Limited Via Business Wire Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session June 04, 2024 Via Benzinga Saia, Annexon, Core Scientific And Other Big Stocks Moving Higher On Tuesday June 04, 2024 Via Benzinga Zai Lab Initiates Global Phase 2 Clinical Trial Evaluating ZL-1102 As a Topical Treatment for Chronic Plaque Psoriasis May 22, 2024 From Zai Lab Limited Via Business Wire Zai Lab and Innoviva Specialty Therapeutics Announce NMPA Approval for XACDURO® (Sulbactam-Durlobactam or SUL-DUR) for Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Acinetobacter Baumannii-Calcoaceticus Complex in China May 20, 2024 From Zai Lab Limited Via Business Wire Zai Lab Announces Participation in May and June Investor Conferences May 16, 2024 From Zai Lab Limited Via Business Wire Zai Lab Announces Acceptance of Supplemental Biologics License Application with Priority Review for Efgartigimod Alfa Injection (Subcutaneous Injection) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China May 14, 2024 From Zai Lab Limited Via Business Wire Zai Lab Announces Approval of AUGTYRO™ (repotrectinib) for Patients with ROS1-positive NSCLC by China’s NMPA May 12, 2024 From Zai Lab Limited Via Business Wire Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session May 09, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session May 09, 2024 Via Benzinga Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036 May 09, 2024 EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:ZLAB),(NASDAQ:NTBL),(NASDAQ:CRDF),(NYSE:JNJ) EQNX::TICKER_END Via FinancialNewsMedia Spectrum Brands Posts Upbeat Results, Joins AerSale, Sinclair, ICU Medical And Other Big Stocks Moving Higher On Thursday May 09, 2024 Via Benzinga Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2 May 09, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session May 09, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday May 09, 2024 Pre-market stock movers are a hot topic this morning and we've got traders covered with all of the news behind these movements on Thursday! Via InvestorPlace ZLAB Stock Earnings: Zai Lab Beats EPS, Beats Revenue for Q1 2024 May 08, 2024 ZLAB stock results show that Zai Lab beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Zai Lab Announces First Quarter 2024 Financial Results and Recent Corporate Updates May 08, 2024 From Zai Lab Limited Via Business Wire Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024 April 15, 2024 From Zai Lab Limited Via Business Wire Zai Lab Statement on Executive Management Team’s Agreement on Share Activities April 11, 2024 From Zai Lab Limited Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.